{"TopicDetails": {"type": 0, "ccm2Id": 43365402, "cftId": 0, "identifier": "JUST-DRUGS-AG", "title": "Supporting initiatives in the Field of Drugs Policy", "publicationDateLong": 1606953600000, "callIdentifier": "JUST-2020-AG-DRUGS", "callTitle": "Call for proposals for action grants to support transnational projects in the area of EU drugs policy", "callccm2Id": 43365413, "allowPartnerSearch": true, "workProgrammepart": {"id": 277564, "ccm_id": 42794294, "wp_part": "JUST-2020", "wp_year": "JUST-2020", "wp_title": "JUST-2020", "wp_website": "http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/index.html", "wp_document": "https://ec.europa.eu/research/participants/data/ref/other_eu_prog/justice/wp/justice-awp-2020_en.pdf"}, "frameworkProgramme": {"id": 31070247, "abbreviation": "JUST", "description": "Justice Programme"}, "programmeDivision": [{"id": 31084407, "abbreviation": "JUST.1.1", "description": "Justice programme 2014-2020"}, {"id": 31070248, "abbreviation": "JUST.1", "description": "Justice programme 2014-2020"}, {"id": 31070252, "abbreviation": "JUST.1.1.4", "description": "Drugs"}], "topicMGAs": [], "tags": ["drugs", "new psychoactive substances", "online trade of drugs", "drug policy", "drug"], "sme": false, "actions": [{"status": {"id": 31094503, "abbreviation": "Closed", "description": "Closed"}, "types": [{"typeOfAction": "JUST-DRUGS-AG HOME Action Grant", "typeOfMGA": []}], "plannedOpeningDate": "03 December 2020", "submissionProcedure": {"id": 31094504, "abbreviation": "single-stage", "description": "single-stage"}, "deadlineDates": ["22 April 2021"]}], "latestInfos": [], "budgetOverviewJSONItem": {"budgetTopicActionMap": {"3363819": [{"action": "JUST-DRUGS-AG - JUST-DRUGS-AG HOME Action Grant", "plannedOpeningDate": "03 December 2020", "deadlineModel": "single-stage", "deadlineDates": ["22 April 2021"], "budgetYearMap": {"2020": 2499000}, "budgetTopicActionMap": {}}]}, "budgetYearsColumns": ["2020"]}, "description": "<SPAN class=\"topicdescriptionkind\">Scope</SPAN>:<p> </p><p><span>Project applications submitted under the present call for proposals must address at least one of the following priorities: </span></p><p><span>- to support activities in the area of epidemiology of use of new psychoactive substances, including potent synthetic opioids, as well as emerging drug problems (notably on challenges related to cocaine and heroin use) and technological developments, including online trade of drugs; </span></p><p><span>- to support the civil society organisations by reinforcing their (i) advocacy function, (ii) capacity to make a difference at the local level, (iii) best practice sharing methods; </span></p><p><span>- to support key stakeholders by expanding their knowledge and skills in the context of implementing minimum quality standards in drug demand reduction (also on development of tools which would allow to measure possible improvements), particularly in the area of social integration and vulnerable groups; </span></p><p><span>- to promote practical application of drug-related research, and, in particular, addiction research with a view of addressing current challenges and new threats. </span></p><p><span><span>The following types of activities are eligible under this call for proposals: </span></span></p><ol style=\"list-style-type:lower-alpha\" level=\"0\">  <li><span><span>analytical activities, such as data collection, development of common methodologies, surveys, research activities, evaluations, workshops, experts meetings; </span></span></li><li><span><span>training activities, such as staff exchanges, workshops, seminars, train-the-trainer events, online trainings;</span></span></li><li><span><span>mutual learning, cooperation, awareness-raising and dissemination activities, such as identification and exchange of good practices, peer reviews, conferences, seminars, information campaigns, publications, ICT systems and tools;</span></span></li><li><span><span>networking activities. </span></span></li> </ol>\n", "conditions": "<p><b><span style=\"font-size:9.0pt;line-height:115%;&#10;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&quot;Times New Roman&quot;;&#10;color:#003366;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:&#10;AR-SA\">1.&nbsp;&nbsp; Eligible countries</span></b></p>\r\n<p>With the exception of international organisations, applicants and co-applicants must be established in the following countries to be eligible: \uf02d</p>\r\n<p>- The Member States of the European Union with the exception of Denmark (&ldquo;Member States participating in the Justice programme&rdquo;)&nbsp;</p>\r\n<p>- Albania and Montenegro</p>\r\n<p>- International organisations can be established outside the above-mentioned countries. <br />\r\n&nbsp;<br />\r\nFor UK applicants: Please note that the United Kingdom is not bound by Regulation (EU) No 1382/2013 establishing the Justice programme and its implementing decisions and UK entities are therefore not eligible to participate under this call.</p>\r\n<p>&nbsp;</p>\n<p><b><span style=\"font-size:9.0pt;line-height:115%;&#10;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&quot;Times New Roman&quot;;&#10;color:#003366;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:&#10;AR-SA\">2.&nbsp;&nbsp; Eligibility and admissibility conditions:</span></b><span style=\"font-size:9.0pt;line-height:115%;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;&#10;mso-fareast-font-family:&quot;Times New Roman&quot;;color:black;mso-ansi-language:EN-GB;&#10;mso-fareast-language:EN-GB;mso-bidi-language:AR-SA\"> </span></p>\r\n<p><span style=\"font-size:10.0pt;&#10;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&quot;Times New Roman&quot;;&#10;mso-fareast-language:EN-GB\">D<span style=\"color: black; font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;; font-size: 9pt; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 115%; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;\">escribed in section 4 of the <a href=\"https://ec.europa.eu/research/participants/data/ref/other_eu_prog/justice/wp-call/call-fiche_just-2020-ag-drugs_en.pdf\" target=\"_blank\">Call document</a>.<br />\r\n&nbsp; &nbsp; &nbsp;&nbsp;</span><br />\r\n</span></p>\r\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span style=\"font-size:10.0pt;&#10;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&quot;Times New Roman&quot;;&#10;mso-fareast-language:EN-GB\"> </span></p>\n<p><b><span style=\"font-size:9.0pt;line-height:115%;&#10;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&quot;Times New Roman&quot;;&#10;color:#003366;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:&#10;AR-SA\">3.&nbsp;&nbsp; Selection criteria:</span></b><span style=\"font-size:9.0pt;line-height:115%;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;&#10;mso-fareast-font-family:&quot;Times New Roman&quot;;color:black;mso-ansi-language:EN-GB;&#10;mso-fareast-language:EN-GB;mso-bidi-language:AR-SA\"> </span></p>\r\n<p>Described in section 6 and 7 of the <a href=\"https://ec.europa.eu/research/participants/data/ref/other_eu_prog/justice/wp-call/call-fiche_just-2020-ag-drugs_en.pdf\" target=\"_blank\">Call document</a>.&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p><span style=\"font-size:9.0pt;line-height:115%;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;&#10;mso-fareast-font-family:&quot;Times New Roman&quot;;color:black;mso-ansi-language:EN-GB;&#10;mso-fareast-language:EN-GB;mso-bidi-language:AR-SA\">&nbsp; &nbsp; &nbsp;</span></p>\r\n<p>&nbsp;</p>\n<p><b><span style=\"font-size:9.0pt;line-height:115%;&#10;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&quot;Times New Roman&quot;;&#10;color:#003366;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:&#10;AR-SA\">4.&nbsp;&nbsp; Indicative timetable for evaluation and grant agreement:</span></b><span style=\"font-size:9.0pt;line-height:115%;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;&#10;mso-fareast-font-family:&quot;Times New Roman&quot;;color:black;mso-ansi-language:EN-GB;&#10;mso-fareast-language:EN-GB;mso-bidi-language:AR-SA\"> </span></p>\r\n<p><font face=\"&quot;Arial&quot;,&quot;sans-serif&quot;\">D<span style=\"color: black; line-height: 115%; font-size: 9pt;\">escribed in section 3 of the <a href=\"https://ec.europa.eu/research/participants/data/ref/other_eu_prog/justice/wp-call/call-fiche_just-2020-ag-drugs_en.pdf\" target=\"_blank\">Call document</a>.</span></font></p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\n<p><span style=\"font-size: 9pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;\">&nbsp;</span></p>\r\n<p><strong><font face=\"&quot;Arial&quot;,&quot;sans-serif&quot;\">5. Proposal templates, evaluation forms and model agreements</font></strong></p>\r\n<p><span style=\"color: rgb(0, 51, 102); font-size: 9pt;\"><span style=\"color: rgb(0, 0, 0);\"><span style=\"color: rgb(0, 51, 102); font-size: 9pt;\"><span style=\"color: rgb(0, 0, 0);\"><span style=\"color: rgb(0, 51, 102); font-size: 9pt;\"><span style=\"color: rgb(0, 0, 0);\"><a href=\"https://ec.europa.eu/research/participants/data/ref/other_eu_prog/common/justdrugs-isfp-isfb-amif_guide-applicants-20_en.pdf\" style=\"color: rgb(40, 151, 183); text-decoration: none;\" target=\"_blank\">Guide for applicants</a></span></span></span></span></span></span><span style=\"background-color: rgb(198, 219, 239); color: rgb(0, 0, 0); display: inline; float: none; font-family: eui-light,Helvetica Neue,Helvetica,sans-serif; font-size: 12.6px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;\"> </span></p>\r\n<p><span style=\"color: rgb(0, 51, 102); font-size: 9pt;\"><span style=\"color: rgb(0, 0, 0);\"><span style=\"color: rgb(0, 51, 102); font-size: 9pt;\"><span style=\"color: rgb(0, 0, 0);\"><span style=\"color: rgb(0, 51, 102); font-size: 9pt;\"><span style=\"color: rgb(0, 0, 0);\"><span style=\"color: rgb(0, 51, 102); font-size: 9pt; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;\"><span style=\"color: rgb(0, 0, 0);\"><a href=\"https://ec.europa.eu/research/participants/data/ref/other_eu_prog/common/tpl/pt/justdrugs-isfp-isfb-amif_call-pt-20_en.pdf\" style=\"color: rgb(40, 151, 183); text-decoration: none;\" target=\"_blank\">Standard proposal template</a></span></span></span></span></span></span></span></span></p>\r\n<p style=\"margin: 0px; padding: 3px 0px; text-align: left; color: rgb(0, 0, 0); text-transform: none; line-height: 1.5; text-indent: 0px; letter-spacing: normal; font-family: eui-light,Helvetica Neue,Helvetica,sans-serif; font-size: 12.6px; font-variant: normal; word-spacing: 0px; white-space: normal; orphans: 2; -webkit-text-stroke-width: 0px;\"><span style=\"font-size: 9pt; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;\"><a href=\"https://ec.europa.eu/research/participants/data/ref/other_eu_prog/common/justdrugs-isfp-isfb-amif_mga-multi_en.pdf\" target=\"_blank\">Multi-beneficiary Model Grant Agreement</a><br />\r\n<br />\r\n</span></p>\r\n<p>&nbsp;</p>\n<p>Members of consortium are required to conclude a consortium agreement, in principle prior to the signature of the grant agreement.</p>\n<p><b><span style=\"font-size:9.0pt;line-height:115%;&#10;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&quot;Times New Roman&quot;;&#10;color:#003366;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:&#10;AR-SA\">6.&nbsp;&nbsp; Additional documents:<br />\r\n</span></b><span style=\"font-size:9.0pt;&#10;line-height:115%;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&quot;Times New Roman&quot;;&#10;color:black;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:&#10;AR-SA\"><br />\r\n&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://ec.europa.eu/research/participants/data/ref/other_eu_prog/justice/wp/justice-awp-2020_en.pdf\" target=\"_blank\">Annual</a></span><span style=\"font-size: 11pt; line-height: 115%; font-family: &quot;Calibri&quot;,&quot;sans-serif&quot;;\"><span style=\"font-size: 9pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;\"><a href=\"https://ec.europa.eu/research/participants/data/ref/other_eu_prog/justice/wp/justice-awp-2020_en.pdf\" target=\"_blank\"> Work Programme</a></span></span></p>\r\n<p><span style=\"font-size: 11pt; line-height: 115%; font-family: &quot;Calibri&quot;,&quot;sans-serif&quot;;\"><span style=\"font-size: 9pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a href=\"https://ec.europa.eu/research/participants/data/ref/other_eu_prog/justice/legal/justice-legalbasis_en.pdf\" target=\"_blank\">Justice Programme legal basis</a></span></span><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;mso-fareast-font-family:&#10;&quot;Times New Roman&quot;;color:black;mso-fareast-language:EN-GB\"><br />\r\n</span></p>\r\n<p><span style=\"font-size: 11pt; line-height: 115%; font-family: &quot;Calibri&quot;,&quot;sans-serif&quot;;\"><span style=\"font-size: 9pt; line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;;\">&nbsp;&nbsp;&nbsp; &nbsp; <a href=\"https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32018R1046&amp;rid=9\" target=\"_blank\">EU Financial Regulation</a></span></span></p>\r\n<p>&nbsp;</p>\r\n<p style=\"color: rgb(0, 0, 0); font-family: eui-light,Helvetica Neue,Helvetica,sans-serif; font-size: 12.6px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 1.5; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; padding-bottom: 3px; padding-left: 0px; padding-right: 0px; padding-top: 3px; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;\">&nbsp;</p>\r\n<p><span style=\"display: inline !important; float: none; background-color: rgb(198, 219, 239); color: rgb(0, 0, 0); font-family: eui-light,Helvetica Neue,Helvetica,sans-serif; font-size: 12.6px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;\"> </span></p>\r\n<p style=\"color: rgb(0, 0, 0); font-family: eui-light,Helvetica Neue,Helvetica,sans-serif; font-size: 12.6px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 1.5; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; orphans: 2; padding-bottom: 3px; padding-left: 0px; padding-right: 0px; padding-top: 3px; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;\">&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p>&nbsp;</p>\r\n<p><br />\r\n&nbsp;</p>", "supportInfo": "<p>Contact the <strong>Justice Programme helpdesk</strong> for further assistance related to the call, topics and the content of proposals <a href=\"mailto:HOME-DRUGS@ec.europa.eu\">HOME-DRUGS@ec.europa.eu</a>.<br />\r\n<br />\r\n<strong><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/faq;categories=;programme=null;actions=;keyword=\" target=\"_blank\">F&amp;T Portal FAQ</a></strong>&nbsp;&ndash; Submission of proposals.<br />\r\n<br />\r\n<strong><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/helpdesks/contact-form\" target=\"_blank\">IT Helpdesk</a></strong>&nbsp;&ndash; contact the IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.<br />\r\n<br />\r\n<strong><a href=\"https://ec.europa.eu/research/participants/docs/h2020-funding-guide/index_en.htm\" target=\"_blank\">H2020 Online Manual</a> - Please use the manual with caution and only for the Participant Portal tools guidance</strong>, i.e. Submission service and Beneficiary register, because it is H2020 specific and does not cover the Justice Programme rules. Some aspects of the Justice Programme are different from the provisions of the H2020 programme.</p>", "sepTemplate": "<p>To access the Electronic Submission Service, please click on the submission-button next to the type of action that corresponds to your proposal. You will then be asked to confirm your choice of the type of action and topic, as these cannot be changed in the submission system. Upon confirmation, you will be linked to the correct entry point.</p>\r\n<p>To access existing draft proposals for this topic, please login to the Funding &amp; Tenders Portal and select the My Proposals page of the My Area section.</p>", "links": [], "additionalDossiers": [], "infoPackDossiers": [], "callDetailsJSONItem": {"additionalInfo": "<p>The aim of this call is to contribute to the effective and coherent application of EU law and to support development of new approaches in the area of drugs, to support initiatives in the field of drugs policy as regards judicial cooperation and crime prevention aspects closely linked to the general objective of the Programme, in so far as they are not covered by the Instrument for financial support for police cooperation, preventing and combating crime, and crisis management, as part of the Internal Security Fund, or by the third Programme for the Union's action in the field of health (2014-2020).</p>", "latestInfos": [{"approvalDate": "Dec 3, 2020 12:00:00 AM", "lastChangeDate": "Dec 3, 2020 12:00:00 AM", "content": "The submission session is now available for: JUST-DRUGS-AG(JUST-DRUGS-AG)"}], "hasForthcomingTopics": false, "hasOpenTopics": false, "allClosedTopics": true}}}